PAB14845
antibody from Abnova Corporation
Targeting: GREM1
CKTSF1B1, CRAC1, DAND2, DRM, gremlin, HMPS
Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PAB14845 - Provider product page
- Provider
- Abnova Corporation
- Proper citation
- Abnova Corporation Cat#PAB14845, RRID:AB_10680827
- Product name
- GREM1 polyclonal antibody
- Antibody type
- Polyclonal
- Antigen
- A synthetic peptide corresponding to amino acids at C-terminus of human GREM1.
- Reactivity
- Human
- Host
- Rabbit
- Vial size
- 100 µg
- Storage
- Store at -20°C on dry atmosphere.After reconstitution with 200 uL of deionized water and concentration will be 500 ug/mL, store at -20°C or lower.Aliquot to avoid repeated freezing and thawing.
Submitted references Expression of gremlin 1 correlates with increased angiogenesis and progression-free survival in patients with pancreatic neuroendocrine tumors.
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor.
The bone morphogenetic protein antagonist gremlin 1 is overexpressed in human cancers and interacts with YWHAH protein.
Skeletal overexpression of gremlin impairs bone formation and causes osteopenia.
Chen MH, Yeh YC, Shyr YM, Jan YH, Chao Y, Li CP, Wang SE, Tzeng CH, Chang PM, Liu CY, Chen MH, Hsiao M, Huang CY
Journal of gastroenterology 2013 Jan;48(1):101-8
Journal of gastroenterology 2013 Jan;48(1):101-8
Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor.
Stabile H, Mitola S, Moroni E, Belleri M, Nicoli S, Coltrini D, Peri F, Pessi A, Orsatti L, Talamo F, Castronovo V, Waltregny D, Cotelli F, Ribatti D, Presta M
Blood 2007 Mar 1;109(5):1834-40
Blood 2007 Mar 1;109(5):1834-40
The bone morphogenetic protein antagonist gremlin 1 is overexpressed in human cancers and interacts with YWHAH protein.
Namkoong H, Shin SM, Kim HK, Ha SA, Cho GW, Hur SY, Kim TE, Kim JW
BMC cancer 2006 Mar 18;6:74
BMC cancer 2006 Mar 18;6:74
Skeletal overexpression of gremlin impairs bone formation and causes osteopenia.
Gazzerro E, Pereira RC, Jorgetti V, Olson S, Economides AN, Canalis E
Endocrinology 2005 Feb;146(2):655-65
Endocrinology 2005 Feb;146(2):655-65
No comments: Submit comment
No validations: Submit validation data